Clustering data with hclust algorithm for Statin Immuno-Metabolomics in Asthma (part IV) (Study ST000846)
Reversed phase POSITIVE ION MODE (Analysis AN001370)| Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 |
|---|---|---|---|---|---|---|---|
| NO-Gly | ME224646 | 0.99 | 1.57 | 1.33 | 1.11 | 0.28 | 0.72 |
| 2-LG | ME224633 | 1.47 | 1.40 | 1.76 | 0.82 | 0.25 | 0.30 |
| SEA | ME224637 | 1.16 | 1.03 | 1.51 | 0.77 | 0.72 | 0.81 |
| Dihomo GLA EA | ME224641 | 1.42 | 1.24 | 1.51 | 0.70 | 0.68 | 0.46 |
| OEA | ME224638 | 1.24 | 1.37 | 1.46 | 0.95 | 0.45 | 0.54 |
| 2-OG | ME224631 | 1.80 | 0.92 | 1.53 | 0.60 | 0.42 | 0.74 |
| 2-AG | ME224635 | 2.06 | 1.06 | 1.58 | 0.71 | 0.23 | 0.36 |
| aLEA | ME224640 | 1.94 | 1.15 | 1.27 | 0.85 | 0.42 | 0.36 |
| DHEA | ME224644 | 1.85 | 0.92 | 0.87 | 0.70 | 1.09 | 0.56 |
| LEA | ME224639 | 1.79 | 0.97 | 1.04 | 0.89 | 0.70 | 0.61 |
| 1-LG | ME224632 | 1.86 | 0.83 | 0.99 | 0.66 | 0.65 | 1.01 |
| DEA | ME224643 | 1.97 | 0.80 | 1.06 | 0.55 | 0.82 | 0.80 |
| 1-AG | ME224634 | 2.03 | 1.02 | 0.92 | 0.68 | 0.54 | 0.82 |
| AEA | ME224642 | 2.16 | 0.98 | 1.06 | 0.60 | 0.65 | 0.55 |
| 1-OG | ME224630 | 1.38 | 0.71 | 1.16 | 0.59 | 0.63 | 1.53 |
| PEA | ME224636 | 0.95 | 1.02 | 0.92 | 0.88 | 1.23 | 1.01 |
| PGF2a EA | ME224645 | 0.87 | 1.31 | 0.98 | 1.09 | 0.98 | 0.76 |
Factors:
| F1 | Tissue:Left Lung | Treatment:Control |
| F2 | Tissue:Left Lung | Treatment:Simvastatin |
| F3 | Tissue:Right Lung | Treatment:Control |
| F4 | Tissue:Right Lung | Treatment:Simvastatin |
| F5 | Tissue:Trachea | Treatment:Control |
| F6 | Tissue:Trachea | Treatment:Simvastatin |
